AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS

被引：0
|
作者：
Laurenti, L. [1 ]
Autore, F. [1 ]
Innocenti, I. [1 ]
D'Arena, G. [2 ]
Coscia, M. [3 ]
Mondello, P. [4 ]
Bellesi, S. [1 ]
Efremov, D. [5 ]
Sica, S. [1 ]
Mauro, F. R. [6 ]
机构：
[1] Univ Cattolica Sacro Cuore, A Gemelli Policlin, I-00168 Rome, Italy
[2] IRCCS Ctr Riferimento Oncol Basilicata, Rionero In Vulture, PZ, Italy
[3] AO Citta Salute & Sci S Giovanni Battista, Turin, Italy
[4] Univ Messina, Dept Human Pathol, Messina, Italy
[5] Monterotondo Scalo, Int Ctr Genet Engn & Biotechnol, Rome, Italy
[6] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P197
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
    Autore, F.
    Innocenti, I.
    D'Arena, G.
    Coscia, M.
    Mondello, P.
    Pasquale, R.
    Sica, S.
    Laurenti, L.
    HAEMATOLOGICA, 2015, 100 : 678 - 679
  • [2] Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience
    Laurenti, Luca
    Autore, Francesco
    Innocenti, Idanna
    D'Arena, Giovanni
    Coscia, Marta
    Mondello, Patrizia
    Chiusolo, Patrizia
    Bellesi, Silvia
    Efremov, Dimitar G.
    Sica, Simona
    Mauro, Francesca Romana
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2429 - 2431
  • [3] Rare side effect of immunochemotherapy with Rituximab/Bendamustine/Prednisolone in a patient with CLL and autoimmune haemolytic anaemia
    Henderson, J. R. M.
    Morche, M.
    Austein, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 154 - +
  • [4] Rituximab in the treatment of autoimmune haemolytic anaemia
    Rodrigo, Chaturaka
    Rajapakse, Senaka
    Gooneratne, Lallindra
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (05) : 709 - 719
  • [5] Treatment of childhood autoimmune haemolytic anaemia with rituximab
    Quartier, P
    Brethon, B
    Philippet, P
    Landman-Parker, J
    Le Deist, F
    Fischer, A
    LANCET, 2001, 358 (9292): : 1511 - 1513
  • [6] Erythema annulare centrifugum during rituximab treatment for autoimmune haemolytic anaemia
    Mendes-Bastos, P.
    Coelho-Macias, V.
    Moraes-Fontes, M. F.
    Milheiro, A.
    Rodrigues, A. M.
    Cardoso, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (08) : 1125 - 1127
  • [7] Rituximab in paediatric autoimmune haemolytic anaemia (AIHA)
    Catala, A.
    Alcorta, I.
    Rives, S.
    Toll, T.
    Tuset, E.
    Estella, J.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 380 - 380
  • [8] Refractory autoimmune haemolytic anaemia in childhood: is there a role for Rituximab?
    Irish Journal of Medical Science, 2001, 170 (Suppl 2)
  • [9] Daratumumab in rituximab-refractory autoimmune haemolytic anaemia
    Rieger, Max J.
    Stolz, Sebastian M.
    Ludwig, Sabine
    Benoit, Tobias M.
    Bissig, Marina
    Widmer, Corinne C.
    Schwotzer, Rahel
    Mueller, Antonia M.
    Nair, Gayathri
    Hegemann, Inga
    Manz, Markus G.
    Schanz, Urs
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (05) : 931 - 934
  • [10] Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)
    Ahrens, N
    Kingreen, D
    Seltsam, A
    Salama, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 244 - 245
12345